Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,276 | -46,010 | -26,016 | -6,058 | 41,798 |
| Depreciation Amortization | 14,489 | 11,555 | 7,681 | 3,754 | 13,132 |
| Income taxes - deferred | -4,000 | -5,680 | -5,028 | -1,682 | 69 |
| Accounts receivable | -10,050 | -7,594 | -1,689 | 2,093 | -8,440 |
| Accounts payable and accrued liabilities | -434 | 1,291 | -348 | 6,119 | -8,533 |
| Other Working Capital | -21,411 | -19,088 | -3,833 | 8,777 | -4,599 |
| Other Operating Activity | 81,583 | 76,686 | 45,154 | 7,366 | 50,866 |
| Operating Cash Flow | $18,901 | $11,160 | $15,921 | $20,369 | $84,293 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -36,057 | -49,716 | -49,515 | -40,688 | -30,101 |
| PPE Investments | -1,201 | -1,000 | -760 | -460 | -1,629 |
| Net Acquisitions | 628 | 628 | 161 | 161 | N/A |
| Investing Cash Flow | $-36,630 | $-50,088 | $-50,114 | $-40,987 | $-31,730 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -277 | N/A | N/A | N/A | N/A |
| Debt Repayment | -1,225 | -1,178 | -816 | -531 | -9,029 |
| Common Stock Issued | 440 | N/A | N/A | N/A | 6,990 |
| Other Financing Activity | -6,892 | -6,834 | -6,572 | -6,448 | -21,712 |
| Financing Cash Flow | $-7,954 | $-8,012 | $-7,388 | $-6,979 | $-23,751 |
| Exchange Rate Effect | -166 | 656 | 416 | 403 | -3,508 |
| Beginning Cash Position | 65,064 | 65,064 | 65,064 | 65,064 | 39,760 |
| End Cash Position | 39,215 | 18,780 | 23,899 | 37,870 | 65,064 |
| Net Cash Flow | $-25,849 | $-46,284 | $-41,165 | $-27,194 | $25,304 |
| Free Cash Flow | |||||
| Operating Cash Flow | 18,901 | 11,160 | 15,921 | 20,369 | 84,293 |
| Capital Expenditure | -1,201 | -1,000 | -760 | -460 | -1,629 |
| Free Cash Flow | 17,700 | 10,160 | 15,161 | 19,909 | 82,664 |